MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5694/mja16.01056

Медицинская библиотека · The Medical journal of Australia · 2017

Management of dengue in Australian travellers: a retrospective multicentre analysis.

Tai Alex Yc, McGuinness Sarah L, Robosa Roselle, Turner David, Huang G Khai Lin, Leder Karin, Korman Tony M, Thevarajan Irani, Stewardson Andrew J, Padiglione Alexander A, Johnson Douglas F

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

OBJECTIVES

To describe the epidemiology, clinical and laboratory features and outcomes of dengue in returned Australian travellers, applying the revised WHO dengue classification (2009) to this population.

DESIGN, SETTING AND

PARTICIPANTS

Retrospective case series analysis of confirmed dengue cases hospitalised at one of four Australian tertiary hospitals, January 2012 - May 2015.

MAIN OUTCOME MEASURES: Clinical features, laboratory findings and outcomes of patients with dengue; dengue classification according to 2009 WHO guidelines.

RESULTS

208 hospitalised patients (median age, 32 years; range, 4-76 years) were included in the study. Dengue was most frequently acquired in Indonesia (94 patients, 45%) and Thailand (40, 19%). The most common clinical features were fever (98% of patients) and headache (76%). 84 patients (40%) met the WHO criteria for dengue with warning signs, and one the criteria for severe dengue; the most common warning signs were mucosal bleeding (44 patients, 21%) and abdominal pain (43, 21%). Leukopenia (176 patients, 85%), thrombocytopenia (133, 64%), and elevated liver enzyme levels (154, 76%) were the most common laboratory findings. 46 patients (22%) had serological evidence of previous exposure to dengue virus. WHO guidelines were documented as a management benchmark in ten cases (5%); 46 patients (22%) received non-steroidal anti-inflammatory drugs (NSAIDs).

CONCLUSIONS

A significant proportion of returning Australian travellers hospitalised for dengue have unrecognised warning signs of severe disease. Many received NSAIDs, which can increase the risk of haemorrhage in dengue. As travel to Asia from Australia continues to increase, it is vital for averting serious outcomes that clinicians can recognise and manage dengue.

Для цитирования: Tai Alex Yc, McGuinness Sarah L, Robosa Roselle, Turner David, Huang G Khai Lin, Leder Karin, Korman Tony M, Thevarajan Irani, Stewardson Andrew J, Padiglione Alexander A, Johnson Douglas F. Management of dengue in Australian travellers: a retrospective multicentre analysis.. The Medical journal of Australia. 2017. DOI: 10.5694/mja16.01056.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.